The RCCX abbreviation is composed of the names of the genes RP (a former name for WHR1 winged helix repair factor 1), C4, CYP21 and TNX).
Structure
The number of RCCX segments varies between one and four in a chromosome, with the prevalence of approximately 15% for monomodular, 75% for bimodular (STK19-C4A-CYP21A1P-TNXA-STK19B-C4B-CYP21A2-TNXB), and 10% for trimodular in Europeans. The quadrimodular structure of the RCCX unit is very rare.
In a monomodular structure, all of the genes are functional i.e. protein-coding, but if a module count is two or more, there is only one copy of each functional gene rest being non-coding pseudogenes with the exception of the C4 gene which always has active copies. Each copy of the C4 gene, due to five adjacent nucleotide substitutions cause four amino acid changes and immunological subfunctionalization (different functions related to the immune system), can be of one of two types: C4A and C4B. Each C4 gene contains 41 exons and has a dichotomous size variation (existence of two distinct sizes) between approximately 22kb and 16kb, with the longer variant being the result of the integration of the endogenous retrovirus HERV-K(C4) into intron 9.
The RCCX module is the most complex gene cluster in the human genome. It is part of the major histocompatibility complex (MHC) class III (MHC class III), which is the most gene-dense region of the human genome, containing many genes that yet have unknown function or structure. RCCX modules exhibit a high degree of linkage disequilibrium, meaning that genes are inherited together more frequently than would be expected by chance. This pattern indicates that there is a non-random association or correlation between the alleles of different genes within the RCCX modules. The high degree of linkage disequilibrium observed in the RCCX modules suggests that the genes within this module are inherited as a group, rather than independently. This grouped inheritance makes the RCCX module well-suited for genetic association studies, especially in the context of autoimmune diseases.
The RP gene (a former name for the WHR1 gene) is involved in cell growth and differentiation, but its exact functions remain unclear. Current knowledge suggests that the STK19/WHR1 gene encodes the protein called nuclear serine/threonine kinase 19. This protein probably plays a role in regulating the activity of neuroblastoma RAS viral oncogene homolog (NRAS), a protein involved in cellular signaling. STK19 phosphorylates NRAS, which means it adds a phosphatefunctional group to NRAS. This phosphorylation event facilitates interactions between NRAS and its downstream effectors, which are molecules that carry out specific cellular functions. By increasing the activation of the mitogen-activated protein kinase (MAPK) cascade, STK19 ultimately influences cellular processes such as cell growth, proliferation, and differentiation.[needs update]
The TNXB gene encodes the Tenascin X, an extracellular matrix glycoprotein. Tenascin X is involved in the formation and maintenance of the extracellular matrix, which provides structural support and regulates cell behavior. Tenascin X is also involved in tissue repair and regeneration and musculoskeletal development. Tenascin X interacts with other extracellular matrix proteins such as fibrillin-1 and collagen and is thought to play a role in regulating their organization and function.
Clinical significance
The RCCX module is related to personality traits such as novelty seeking and impulsivity as major histocompatibility complex (MHC), where the RCCX module is located, may affect these traits through its role in immune function and neurodevelopment, still, the exact mechanisms are not fully understood.
The TNXB gene, also known as tenascin-X, is associated with such disorders of connective tissue, such as Ehlers–Danlos syndrome (EDS), characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. Another disorder, when recombination events occur between a pseudogene TNXA and the functional gene TNXB within the RCCX module, resulting in CYP21A2 deletion along with impaired TNXB function, is called CAH-X Syndrome and leads to both congenital adrenal hyperplasia (CAH) symptoms and features consistent with EDS. This impaired function of the TNXB gene refers to the decreased production or abnormal structure of the tenascin-X protein due to genetic changes within the TNXB gene. The exact molecular mechanisms through which alterations or deficiencies in the TNXB gene or its impaired function lead to these conditions (the EDS and the CAH-X syndrome) are not fully understood yet but are believed to be related to defects in extracellular matrix organization and cell adhesion processes mediated by tenascin-X protein.
References
↑Chang SF, Lee HH (2011). "Analysis of the CYP21A2 gene with intergenic recombination and multiple gene deletions in the RCCX module". Genet Test Mol Biomarkers. 15 (1–2): 35–42. doi:10.1089/gtmb.2010.0080. PMID21117955.
↑Yu CY, Chung EK, Yang Y, Blanchong CA, Jacobsen N, Saxena K, Yang Z, Miller W, Varga L, Fust G (2003). "Dancing with Complement C4 and the RP-C4-CYP21-TNX (RCCX) Modules of the Major Histocompatibility Complex". Prog Nucleic Acid Res Mol Biol. Progress in Nucleic Acid Research and Molecular Biology. 75: 217–292. doi:10.1016/s0079-6603(03)75007-7. ISBN978-0-12-540075-6. PMID14604014.{{cite journal}}: CS1 maint: periodical has ISBN (link)
↑Rupert KL, Rennebohm RM, Yu CY (1999). "An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis". Exp Clin Immunogenet. 16 (2): 81–97. doi:10.1159/000019099. PMID10343159. S2CID24623016.
↑Wu Z, Zhang S, Li P, Zhang F, Li Y (November 2020). "Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis". Clin Exp Med. 20 (4): 627–634. doi:10.1007/s10238-020-00640-5. PMID32691186. S2CID220638363.
↑Tsang-A-Sjoe MW, Bultink IE, Korswagen LA, van der Horst A, Rensink I, de Boer M, Hamann D, Voskuyl AE, Wouters D (December 2017). "Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity". Mol Immunol. 92: 125–131. doi:10.1016/j.molimm.2017.10.004. PMID29080553. S2CID10363726.
↑Mack M, Bender K, Schneider PM (August 2004). "Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region". Immunogenetics. 56 (5): 321–332. doi:10.1007/s00251-004-0705-y. PMID15309346. S2CID7128183.
↑Nimkarn S, Gangishetti PK, Yau M, New MI (4 February 2016) [26 February 2002]. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, Amemiya A (eds.). "21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia"(PDF). GeneReviews. PMID20301350. NBK1171. Archived(PDF) from the original on 6 November 2022. Retrieved 8 March 2024.